Cathrin Brisken

Summary

Affiliation: University of Lausanne
Country: Switzerland

Publications

  1. ncbi Hormonal control of alveolar development and its implications for breast carcinogenesis
    Cathrin Brisken
    Surgical Oncology, MGH Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Mammary Gland Biol Neoplasia 7:39-48. 2002
  2. ncbi Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective
    Cathrin Brisken
    NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research ISREC, 155 Chemin des Boveresses, Epalinges s Lausanne, CH 1066, Switzerland
    Stem Cell Rev 3:147-56. 2007
  3. ncbi Prolactin signaling and Stat5: going their own separate ways?
    Cathrin Brisken
    Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland
    Breast Cancer Res 4:209-12. 2002
  4. ncbi IGF-2 is a mediator of prolactin-induced morphogenesis in the breast
    Cathrin Brisken
    Department of Surgical Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA
    Dev Cell 3:877-87. 2002
  5. ncbi Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development
    Laura Ciarloni
    Swiss Institute for Experimental Cancer Research, National Center of Competence in Research, Molecular Oncology, Chemin des Boveresses 155, CH 1066 Epalinges, Switzerland
    Proc Natl Acad Sci U S A 104:5455-60. 2007
  6. ncbi Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression
    Chuanwei Yang
    Cancer Research Center at Massachusetts General Hospital, 55 Fruit Street, GRJ 9th floor, Boston, MA 02114, USA
    Mol Cell Biol 30:3111-25. 2010
  7. ncbi Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland
    Sonia Mallepell
    National Center of Competence in Research Molecular Oncology, Swiss Institute for Experimental Cancer Research, 155 Chemin des Boveresses, CH 1066 Epalinges s Lausanne, Switzerland
    Proc Natl Acad Sci U S A 103:2196-201. 2006
  8. ncbi Alveolar and lactogenic differentiation
    Cathrin Brisken
    National Center of Competence in Research NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research ISREC, 155 Chemin des Boveresses, CH 1066, Epalinges, Lausanne, Switzerland
    J Mammary Gland Biol Neoplasia 11:239-48. 2006
  9. ncbi Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism
    Ayyakannu Ayyanan
    Swiss Institute for Experimental Cancer Research, National Center of Competence in Research in Molecular Oncology, 155 Chemin des Boveresses, CH 1066 Epalinges Lausanne, Switzerland
    Proc Natl Acad Sci U S A 103:3799-804. 2006
  10. ncbi Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis
    Bing Hu
    Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
    Genes Dev 24:1519-32. 2010

Collaborators

Detail Information

Publications18

  1. ncbi Hormonal control of alveolar development and its implications for breast carcinogenesis
    Cathrin Brisken
    Surgical Oncology, MGH Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Mammary Gland Biol Neoplasia 7:39-48. 2002
    ..This paper focuses on this final stage of proliferation, the formation of alveolar structures and its control by systemic hormones...
  2. ncbi Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective
    Cathrin Brisken
    NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research ISREC, 155 Chemin des Boveresses, Epalinges s Lausanne, CH 1066, Switzerland
    Stem Cell Rev 3:147-56. 2007
    ....
  3. ncbi Prolactin signaling and Stat5: going their own separate ways?
    Cathrin Brisken
    Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland
    Breast Cancer Res 4:209-12. 2002
    ..revealed defects in the epithelial architecture of the smallest ducts of Stat5ab-/- transplants not apparent in the PrlR-/- transplants, suggesting that Stat5 is more than a simple mediator of PrlR action...
  4. ncbi IGF-2 is a mediator of prolactin-induced morphogenesis in the breast
    Cathrin Brisken
    Department of Surgical Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA
    Dev Cell 3:877-87. 2002
    ..Thus, IGF-2 is a mediator of prolactin-induced alveologenesis; prolactin, IGF-2, and cyclin D1, all of which are overexpressed in breast cancers, are components of a developmental pathway in the mammary gland...
  5. ncbi Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development
    Laura Ciarloni
    Swiss Institute for Experimental Cancer Research, National Center of Competence in Research, Molecular Oncology, Chemin des Boveresses 155, CH 1066 Epalinges, Switzerland
    Proc Natl Acad Sci U S A 104:5455-60. 2007
    ..Thus, amphiregulin is an important paracrine mediator of estrogen function specifically required for puberty-induced ductal elongation, but not for any earlier or later developmental stages...
  6. ncbi Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression
    Chuanwei Yang
    Cancer Research Center at Massachusetts General Hospital, 55 Fruit Street, GRJ 9th floor, Boston, MA 02114, USA
    Mol Cell Biol 30:3111-25. 2010
    ..Additionally, its regulation of the progesterone receptor identifies a novel role for cyclin D1 in ovarian hormone control of breast development and breast carcinogenesis...
  7. ncbi Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland
    Sonia Mallepell
    National Center of Competence in Research Molecular Oncology, Swiss Institute for Experimental Cancer Research, 155 Chemin des Boveresses, CH 1066 Epalinges s Lausanne, Switzerland
    Proc Natl Acad Sci U S A 103:2196-201. 2006
    ....
  8. ncbi Alveolar and lactogenic differentiation
    Cathrin Brisken
    National Center of Competence in Research NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research ISREC, 155 Chemin des Boveresses, CH 1066, Epalinges, Lausanne, Switzerland
    J Mammary Gland Biol Neoplasia 11:239-48. 2006
    ..The powerful tools of mouse genetics have been instrumental in uncovering many of the signaling components involved in controlling alveolar and lactogenic differentiation...
  9. ncbi Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism
    Ayyakannu Ayyanan
    Swiss Institute for Experimental Cancer Research, National Center of Competence in Research in Molecular Oncology, 155 Chemin des Boveresses, CH 1066 Epalinges Lausanne, Switzerland
    Proc Natl Acad Sci U S A 103:3799-804. 2006
    ....
  10. ncbi Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis
    Bing Hu
    Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
    Genes Dev 24:1519-32. 2010
    ..Thus, Notch/CSL signaling plays a unique function in control of hair follicle differentiation by the underlying mesenchyme, with Wnt5a signaling and FoxN1 as mediators...
  11. ncbi Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function
    Sandra Gass
    Swiss Institute for Experimental Cancer Research, National Center of Competence in Research Molecular Oncology, Epalinges s/Lausanne, Switzerland
    J Mammary Gland Biol Neoplasia 8:269-85. 2003
    ..Some of the candidates have been implicated in tumorigenesis. The relevance and validation of microarray data, as well as comparison of the results obtained by different groups, will be discussed...
  12. ncbi The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium
    Cathrin Brisken
    Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
    Proc Natl Acad Sci U S A 99:14241-5. 2002
    ....
  13. ncbi The epithelial-mesenchymal transition generates cells with properties of stem cells
    Sendurai A Mani
    Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA
    Cell 133:704-15. 2008
    ..These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties...
  14. ncbi An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells
    Stephan Duss
    NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research ISREC, Chemin des Boveresses 155, CH 1066 Epalinges, Switzerland
    Breast Cancer Res 9:R38. 2007
    ..To create an ERalpha-positive breast cancer model, we have forced normal HMECs derived from reduction mammoplasty tissue to express ERalpha in combination with other relevant breast cancer genes...
  15. ncbi Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis
    Emily Y Chu
    Departments of Dermatology and Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Development 131:4819-29. 2004
    ..WNT signals play similar roles in hair follicle formation and thus may be broadly required for induction of skin appendage morphogenesis...
  16. ncbi Identification of molecular apocrine breast tumours by microarray analysis
    Pierre Farmer
    Swiss Institute of Bioinformatics, Lausanne, Switzerland
    Oncogene 24:4660-71. 2005
    ..Our data show that it is possible with microarray data to divide mammary tumour cells into three groups based on steroid receptor activity: luminal (ER+ AR+), basal (ER- AR-) and molecular apocrine (ER- AR+)...
  17. ncbi p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation
    Vikram Devgan
    Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
    Genes Dev 19:1485-95. 2005
    ..Thus, p21 acts as a selective negative regulator of transcription and links the Notch and Wnt signaling pathways in keratinocyte growth control...
  18. ncbi The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer
    Anne Boulay
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
    Cancer Res 68:3743-51. 2008
    ..In summary, we showed that Ret is a novel proliferative pathway interacting with ER signaling in vitro. Expression of Ret in primary breast tumors suggests that Ret might be a novel therapeutic target in breast cancer...